VALN - Valneva wins EU backing for Chikungunya vaccine May, 31 2024 11:37 AM Valneva SE 2024-05-31 11:37:15 ET More on Valneva Valneva SE (VALN) Q4 2023 Earnings Call Transcript Valneva GAAP EPS of -€0.73, revenue of €153.71M; updates FY24 guidance Seeking Alpha’s Quant Rating on Valneva Historical earnings data for Valneva Financial information for Valneva For further details see: Valneva wins EU backing for Chikungunya vaccine